Reinmuth N - Search Results

1

Novel angiogenesis inhibitors in nonsmall cell lung cancer.

Reinmuth N, Heigener D, Reck M. Reinmuth N, et al. Curr Opin Oncol. 2015 Mar;27(2):79-86. doi: 10.1097/CCO.0000000000000166. Curr Opin Oncol. 2015. PMID: 25602682 Review.

2

Molecular determinants of response to RTK-targeting agents in nonsmall cell lung cancer.

Reinmuth N, Meister M, Muley T, Steins M, Kreuter M, Herth FJ, Hoffmann H, Dienemann H, Thomas M. Reinmuth N, et al. Int J Cancer. 2006 Aug 15;119(4):727-34. doi: 10.1002/ijc.21750. Int J Cancer. 2006. PMID: 16557579 Review.

3

[Current developments and perspectives in targeted therapies].

Dickgreber N, Huber RM, Reck M, Reinmuth N, Schütte W, Serke M, Wolf J. Dickgreber N, et al. Among authors: reinmuth n. Onkologie. 2010;33 Suppl 5:2-11. doi: 10.1159/000313971. Epub 2010 May 14. Onkologie. 2010. PMID: 20523101 Free article. Review. German.

4

Targeting the epidermal growth factor receptor in non-small cell lung cancer.

Steins MB, Reinmuth N, Bischoff H, Kindermann M, Thomas M. Steins MB, et al. Among authors: reinmuth n. Onkologie. 2010;33(12):704-9. doi: 10.1159/000322214. Epub 2010 Nov 26. Onkologie. 2010. PMID: 21124044 Review.

5

Characteristics of lung cancer after a previous malignancy.

Reinmuth N, Stumpf P, Stumpf A, Muley T, Kobinger S, Hoffmann H, Herth FJ, Schnabel PA, Bischoff H, Thomas M. Reinmuth N, et al. Respir Med. 2014 Jun;108(6):910-7. doi: 10.1016/j.rmed.2014.02.015. Epub 2014 Mar 5. Respir Med. 2014. PMID: 24650574 Free article.

6

The tissue is the issue: improved methylome analysis from paraffin-embedded tissues by application of the HOPE technique.

Marwitz S, Kolarova J, Reck M, Reinmuth N, Kugler C, Schädlich I, Haake A, Zabel P, Vollmer E, Siebert R, Goldmann T, Ammerpohl O. Marwitz S, et al. Among authors: reinmuth n. Lab Invest. 2014 Aug;94(8):927-33. doi: 10.1038/labinvest.2014.79. Epub 2014 Jun 16. Lab Invest. 2014. PMID: 24933424 Free article.

7

Nintedanib for the treatment of patients with advanced non-small-cell lung cancer.

Reck M, Heigener D, Reinmuth N. Reck M, et al. Among authors: reinmuth n. Expert Rev Clin Pharmacol. 2014 Sep;7(5):579-90. doi: 10.1586/17512433.2014.945430. Expert Rev Clin Pharmacol. 2014. PMID: 25119062 Review.

8

[Non-small cell lung cancer: news from immunotherapy].

Reinmuth N, Heigener DF, Reck M. Reinmuth N, et al. Dtsch Med Wochenschr. 2015 Mar;140(5):329-33. doi: 10.1055/s-0041-100763. Epub 2015 Mar 3. Dtsch Med Wochenschr. 2015. PMID: 25734674 Review. German.

9

Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer.

Thomas M, Fischer J, Andreas S, Kortsik C, Grah C, Serke M, von Eiff M, Witt C, Kollmeier J, Müller E, Schenk M, Schröder M, Villalobos M, Reinmuth N, Penzel R, Schnabel P, Acker T, Reuss A, Wolf M; ABC-Lung Cancer Group. Thomas M, et al. Among authors: reinmuth n. Eur Respir J. 2015 Jul;46(1):219-29. doi: 10.1183/09031936.00229014. Epub 2015 Mar 18. Eur Respir J. 2015. PMID: 25792638 Free article. Clinical Trial.

10

Combinations Therapies.

Reinmuth N, Reck M. Reinmuth N, et al. Prog Tumor Res. 2015;42:79-94. doi: 10.1159/000437186. Epub 2015 Sep 4. Prog Tumor Res. 2015. PMID: 26384009 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page